Bibliographic record
Abstract
Four properties define exosomes. First, they are tiny bodies–as small as 35 nm in diameter, 1,000 times less than the width of a human hair—that perform key assignments in cell signaling and other biological processes. Second, their size aids in transiting hard-to-navigate tissue boundaries in the body, such as the brain–blood barrier and the gut–blood barrier, optioning an oral administration of therapy in some instances. Third, since they can convey protein peptides, nucleic acids, and small molecule drugs, they represent an amalgam of proteomic, genomic, and lipidomic concepts in biomedicine. And fourth, it is conceivable, exosomes can address any human disease—many of which cannot be accessed today—even using material from other species. Two research groups—in St. Louis and Montreal—first characterized them almost simultaneously in 1984, offering an explanation of how immature red blood cells lost their iron-transporting transferrin receptor when they matured. Their role as intercellular communicators grew in 1996 when researchers at the University of Utrecht showed how exosomes induced a powerful immune response that caused cancerous tumors to regress. They travel in every body fluid: blood, lymph, urine, tears, saliva, cerebrospinal, and mother’s milk. Originally seen in electron micrographs and thought to be inconsequential, they now have a presence in biotechnology as a new platform for diagnostics and therapy, broadly representing proteome medicine. As yet, they have not reached a critical mass for clinical adoption, though their prospects are tantalizing. This piece ends with a prediction—that by 2034, the 50th anniversary of the term exosome, proteome medicine will have several generally recognized as safe and effective exosome-based prescriptions, with China leading the way.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.007 | 0.009 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.002 | 0.001 |
| Bibliometrics | 0.002 | 0.001 |
| Science and technology studies | 0.002 | 0.012 |
| Scholarly communication | 0.010 | 0.022 |
| Open science | 0.002 | 0.006 |
| Research integrity | 0.005 | 0.009 |
| Insufficient payload (model declined to judge) | 0.006 | 0.006 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".